BSE filing, NSE: SOFTTECH. Summary written from the filing by ALFA Finder's alert engine.
SoftTech Engineers Ltd: key numbers
- Share price
- ₹458.00
- Market cap
- ₹634.0 Cr
- Revenue (annual)
- ₹132.9 Cr
- Net profit (annual)
- ₹4.94 Cr
- P/E (TTM)
- 128.3×Sector 23.6×
- Promoter holding
- 18.88%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SoftTech Engineers Ltd
All →SoftTech Engineers Management Change
Softtech Engineers Limited appointed Mr. Nihal Gupta as Company Secretary and Compliance Officer, effective 4 November 2026. He brings 5.5 years of secretarial and compliance experience and is an ICSI Associate Member.
SoftTech Engineers Q2 FY27 Results: Net Profit ₹0.2 Cr, Down 33.3% YoY
SoftTech Engineers Ltd reported revenue from operations of ₹31.5 Cr (+17.5% YoY) and net profit of ₹0.2 Cr (-33.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.2 Cr · -33.3% YoY
SoftTech Engineers Board Meeting Date
Softtech Engineers intimated that its Board of Directors will meet on 4 Nov 2026 to consider unaudited financial results for Q2/H1 FY27. The trading window will reopen from 7 Nov 2026.
SoftTech Engineers Other Announcement
SoftTech Engineers submitted its quarterly Reg 76 share capital audit reconciliation for September 30, 2026. The routine certificate confirms issued capital matches listed and demat records.
SoftTech Engineers Other Announcement
Softtech Engineers Limited announced the re-appointment of Rakesh Kumar Singh as an Independent Director and M/s. P G Bhagwat LLP as the Statutory Auditor for five-year terms.
SoftTech Engineers Annual General Meeting
SoftTech Engineers Limited held its 30th Annual General Meeting on September 29, 2026, via video conferencing to transact various ordinary and special business items.
Other other announcement announcements
All →Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.
Gujarat Kidney and Super Speciality Other Announcement
Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.
PDS Other Announcement
PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.